|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
3
|
Gu Y, Ma C, Zou J, Zhu Y, Yang R, Xu Y and
Zhang Y: Prevalence characteristics of high-risk human
papillomaviruses in women living in Shanghai with cervical
precancerous lesions and cancer. Oncotarget. 7:24656–24663.
2016.PubMed/NCBI
|
|
4
|
Mayadev J, Lim J, Durbin-Johnson B,
Valicenti R and Alvarez E: Smoking decreases survival in locally
advanced cervical cancer treated with radiation. Am J Clin Oncol.
Jan 22–2016.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Santesso N, Mustafa RA, Schünemann HJ,
Arbyn M, Blumenthal PD, Cain J, Chirenje M, Denny L, De Vuyst H,
Eckert LO, et al Guideline Support Group: World Health Organization
Guidelines for treatment of cervical intraepithelial neoplasia 2–3
and screen-and-treat strategies to prevent cervical cancer. Int J
Gynaecol Obstet. 132:252–258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Crafton SM and Salani R: Beyond
chemotherapy: An overview and review of targeted therapy in
cervical cancer. Clin Ther. 38:449–458. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun F, Xiong Y, Zhou XH, Li Q, Xiao L,
Long P, Li LJ, Cai MY, Wei YX, Ma YL, et al: Acylglycerol kinase is
over-expressed in early-stage cervical squamous cell cancer and
predicts poor prognosis. Tumour Biol. 37:6729–6736. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hou T, Liang D, Xu L, Huang X, Huang Y and
Zhang Y: Atypical chemokine receptors predict lymph node metastasis
and prognosis in patients with cervical squamous cell cancer.
Gynecol Oncol. 130:181–187. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hou T, Liang D, Yang D, He J, Huang Y and
Zhang Y: High expression of CRAM correlates with poor prognosis in
patients with cervical carcinoma. Int J Clin Exp Pathol.
7:1060–1068. 2014.PubMed/NCBI
|
|
10
|
Zhang W, Ou J, Lei F, Hou T, Wu S, Niu C,
Xu L and Zhang Y: C14ORF166 overexpression is associated with
pelvic lymph node metastasis and poor prognosis in uterine cervical
cancer. Tumour Biol. 37:369–379. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang W, Hou T, Niu C, Song L and Zhang Y:
B3GNT3 Expression is a novel marker correlated with pelvic lymph
node metastasis and poor clinical outcome in early-stage cervical
cancer. PLoS One. 10:e01443602015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang L, Huang H, Zhang L, Hou T, Wu S,
Huang Q, Song L and Liu J: URG4 overexpression is correlated with
cervical cancer progression and poor prognosis in patients with
early-stage cervical cancer. BMC Cancer. 14:8852014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu L, Xia M, Wang J, Zhang W, Zhang Y and
He M: CISD2 expression is a novel marker correlating with pelvic
lymph node metastasis and prognosis in patients with early-stage
cervical cancer. Med Oncol. 31:1832014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hou T, Zhang W, Tong C, Kazobinka G, Huang
X, Huang Y and Zhang Y: Putative stem cell markers in cervical
squamous cell carcinoma are correlated with poor clinical outcome.
BMC Cancer. 15:7852015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Unsal-Kacmaz K, Mullen TE, Kaufmann WK and
Sancar A: Coupling of human circadian and cell cycles by the
timeless protei. Mol Cell Biol. 25:3109–3116. 2005. View Article : Google Scholar
|
|
16
|
Gotter AL, Suppa C and Emanuel BS:
Mammalian TIMELESS and Tipin are evolutionarily conserved
replication fork-associated factors. J Mol Biol. 366:36–52. 2007.
View Article : Google Scholar
|
|
17
|
Urtishak KA, Smith KD, Chanoux RA,
Greenberg RA, Johnson FB and Brown EJ: Timeless maintains genomic
stability and suppresses sister chromatid exchange during
unperturbed DNA replication. J Biol Chem. 284:8777–8785. 2009.
View Article : Google Scholar :
|
|
18
|
Stevens RG: Circadian disruption and
breast cancer: From melatonin to clock genes. Epidemiology.
16:254–258. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshida K, Sato M, Hase T, Elshazley M,
Yamashita R, Usami N, Taniguchi T, Yokoi K, Nakamura S, Kondo M, et
al: TIMELESS is overexpressed in lung cancer and its expression
correlates with poor patient survival. Cancer Sci. 104:171–177.
2013. View Article : Google Scholar
|
|
20
|
Fu A, Leaderer D, Zheng T, Hoffman AE,
Stevens RG and Zhu Y: Genetic and epigenetic associations of
circadian gene TIMELESS and breast cancer risk. Mol Carcinog.
51:923–929. 2012. View
Article : Google Scholar
|
|
21
|
Dong H, Claffey KP, Brocke S and Epstein
PM: Expression of phosphodiesterase 6 (PDE6) in human breast cancer
cells. Springerplus. 2:6802013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tozlu-Kara S, Roux V, Andrieu C, Vendrell
J, Vacher S, Lazar V, Spyratos F, Tubiana-Hulin M, Cohen P, Dessen
P, et al: Oligonucleotide microarray analysis of estrogen receptor
a-positive postmenopausal breast carcinomas: Identification of
HRPAP20 and TIMELESS as outstanding candidate markers to predict
the response to tamoxifen. J Mol Endocrinol. 39:305–318. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Elgohary N, Pellegrino R, Neumann O,
Elzawahry HM, Saber MM, Zeeneldin AA, Geffers R, Ehemann V,
Schemmer P, Schirmacher P, et al: Protumorigenic role of Timeless
in hepato-cellular carcinoma. Int J Oncol. 46:597–606. 2015.
|
|
24
|
Chiang YT, Gout PW, Collins CC and Wang Y:
Prostate cancer metastasis-driving genes: Hurdles and potential
approaches in their identification. Asian J Androl. 16:545–548.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mazzoccoli G, Panza A, Valvano MR, Palumbo
O, Carella M, Pazienza V, Biscaglia G, Tavano F, Di Sebastiano P,
Andriulli A, et al: Clock gene expression levels and relationship
with clinical and pathological features in colorectal cancer
patients. Chronobiol Int. 28:841–851. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kemp MG, Akan Z, Yilmaz S, Grillo M,
Smith-Roe SL, Kang TH, Cordeiro-Stone M, Kaufmann WK, Abraham RT,
Sancar A, et al: Tipin-replication protein A interaction mediates
Chk1 phosphorylation by ATR in response to genotoxic stress. J Biol
Chem. 285:16562–16571. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang X, Wood PA and Hrushesky WJ:
Mammalian TIMELESS is required for ATM-dependent CHK2 activation
and G2/M checkpoint control. J Biol Chem. 285:3030–3034. 2010.
View Article : Google Scholar :
|
|
28
|
Mazzoccoli G, Piepoli A, Carella M, Panza
A, Pazienza V, Benegiamo G, Palumbo O and Ranieri E: Altered
expression of the clock gene machinery in kidney cancer patients.
Biomed Pharmacother. 66:175–179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schepeler T, Lamy P, Hvidberg V, Laurberg
JR, Fristrup N, Reinert T, Bartkova J, Tropia L, Bartek J,
Halazonetis TD, et al: A high resolution genomic portrait of
bladder cancer: Correlation between genomic aberrations and the DNA
damage response. Oncogene. 32:3577–3586. 2013. View Article : Google Scholar
|
|
30
|
Relles D, Sendecki J, Chipitsyna G, Hyslop
T, Yeo CJ and Arafat HA: Circadian gene expression and
clinicopathologic correlates in pancreatic cancer. J Gastrointest
Surg. 17:443–450. 2013. View Article : Google Scholar
|
|
31
|
Gerber JM, Gucwa JL, Esopi D, Gurel M,
Haffner MC, Vala M, Nelson WG, Jones RJ and Yegnasubramanian S:
Genome-wide comparison of the transcriptomes of highly enriched
normal and chronic myeloid leukemia stem and progenitor cell
populations. Oncotarget. 4:715–728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang W, Niu C, He W, Hou T, Sun X, Xu L
and Zhang Y: Upregulation of centrosomal protein 55 is associated
with unfavorable prognosis and tumor invasion in epithelial ovarian
carcinoma. Tumour Biol. 37:6239–6254. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shiraishi N, Natsume A, Togayachi A, Endo
T, Akashima T, Yamada Y, Imai N, Nakagawa S, Koizumi S, Sekine S,
et al: Identification and characterization of three novel beta
1,3-N-acetylglucosaminyltransferases structurally related to the
beta 1,3-galactosyltransferase family. J Biol Chem. 276:3498–3507.
2001. View Article : Google Scholar
|
|
34
|
He M, Wu C, Xu J, Guo H, Yang H, Zhang X,
Sun J, Yu D, Zhou L, Peng T, et al: A genome wide association study
of genetic loci that influence tumour biomarkers cancer antigen
19–9, carcinoembryonic antigen and α fetoprotein and their
associations with cancer risk. Gut. 63:143–151. 2014. View Article : Google Scholar
|
|
35
|
Ho WL, Che MI, Chou CH, Chang HH, Jeng YM,
Hsu WM, Lin KH and Huang MC: B3GNT3 expression suppresses cell
migration and invasion and predicts favorable outcomes in
neuroblastoma. Cancer Sci. 104:1600–1608. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang S, Liu Y, Xia B, Deng J, Liu T, Li Q,
Yang Y, Wang Y, Ning X, Zhang Y, et al: DLL4 as a predictor of
pelvic lymph node metastasis and a novel prognostic biomarker in
patients with early-stage cervical cancer. Tumour Biol.
37:5063–5074. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM,
Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dorigo O, et al:
Cervical Cancer, Version 2.2015. J Natl Compr Canc Netw.
13:395–404; quiz 404. 2015.PubMed/NCBI
|
|
38
|
Pol FJ, Zusterzeel PL, van Ham MA,
Kuijpers DA, Bulten J and Massuger LF: Satellite lymphovascular
space invasion: An independent risk factor in early stage cervical
cancer. Gynecol Oncol. 138:579–584. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lan ML, Yu X, Xiao H, Zhou P, Hu N, Li J
and Wang G: Clinical outcomes and toxicity of postoperative
intensity-modulated versus three-dimensional conformal radiation
therapy in patients with cervical cancer. Asia Pac J Clin Oncol.
Feb 28–2016.Epub ahead of print. View Article : Google Scholar
|
|
40
|
Ikeda Y, Furusawa A, Kitagawa R, Tokinaga
A, Ito F, Ukita M, Nomura H, Yamagami W, Tanabe H, Mikami M, et al:
Practice patterns of adjuvant therapy for intermediate/high
recurrence risk cervical cancer patients in Japan. J Gynecol Oncol.
27:e292016. View Article : Google Scholar : PubMed/NCBI
|
